Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo

J Neurosci. 2000 Dec 1;20(23):8597-603. doi: 10.1523/JNEUROSCI.20-23-08597.2000.

Abstract

Transforming growth factor-betas (TGF-betas) constitute an expanding family of multifunctional cytokines with prominent roles in development, cell proliferation, differentiation, and repair. We have cloned, expressed, and raised antibodies against a distant member of the TGF-betas, growth/differentiation factor-15 (GDF-15). GDF-15 is identical to macrophage inhibitory cytokine-1 (MIC-1). GDF-15/MIC-1 mRNA and protein are widely distributed in the developing and adult CNS and peripheral nervous systems, including choroid plexus and CSF. GDF-15/MIC-1 is a potent survival promoting and protective factor for cultured and iron-intoxicated dopaminergic (DAergic) neurons cultured from the embryonic rat midbrain floor. The trophic effect of GDF-15/MIC-1 was not accompanied by an increase in cell proliferation and astroglial maturation, suggesting that GDF-15/MIC-1 probably acts directly on neurons. GDF-15/MIC-1 also protects 6-hydroxydopamine (6-OHDA)-lesioned nigrostriatal DAergic neurons in vivo. Unilateral injections of GDF-15/MIC-1 into the medial forebrain bundle just above the substantia nigra (SN) and into the left ventricle (20 microgram each) immediately before a 6-OHDA injection (8 microgram) prevented 6-OHDA-induced rotational behavior and significantly reduced losses of DAergic neurons in the SN. This protection was evident for at least 1 month. Administration of 5 microgram of GDF-15/MIC-1 in the same paradigm also provided significant neuroprotection. GDF-15/MIC-1 also promoted the serotonergic phenotype of cultured raphe neurons but did not support survival of rat motoneurons. Thus, GDF-15/MIC-1 is a novel neurotrophic factor with prominent effects on DAergic and serotonergic neurons. GDF-15/MIC-1 may therefore have a potential for the treatment of Parkinson's disease and disorders of the serotonergic system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cloning, Molecular
  • Corpus Striatum / drug effects
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Cytokines / pharmacology
  • Dopamine / metabolism*
  • Female
  • Growth Differentiation Factor 15
  • Humans
  • Iron / pharmacology
  • Kinesis / drug effects
  • Mesencephalon / cytology
  • Mesencephalon / drug effects
  • Mesencephalon / embryology
  • Mesencephalon / metabolism*
  • Motor Neurons / cytology
  • Motor Neurons / drug effects
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Organ Specificity
  • Oxidopamine / antagonists & inhibitors
  • Raphe Nuclei / cytology
  • Raphe Nuclei / drug effects
  • Raphe Nuclei / embryology
  • Raphe Nuclei / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Serotonin / metabolism
  • Spinal Cord
  • Substantia Nigra / drug effects
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism*
  • Transforming Growth Factor beta / pharmacology

Substances

  • Cytokines
  • GDF15 protein, human
  • Gdf15 protein, rat
  • Growth Differentiation Factor 15
  • Transforming Growth Factor beta
  • Serotonin
  • Oxidopamine
  • Iron
  • Dopamine